0001237899-20-000015.txt : 20200403
0001237899-20-000015.hdr.sgml : 20200403
20200403160551
ACCESSION NUMBER: 0001237899-20-000015
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200401
FILED AS OF DATE: 20200403
DATE AS OF CHANGE: 20200403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fenimore Christopher R.
CENTRAL INDEX KEY: 0001697422
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 20773351
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-04-01
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001697422
Fenimore Christopher R.
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
VP Controller
Common Stock
2020-04-01
4
M
0
1200
30.63
A
14297
D
Common Stock
2020-04-01
4
S
0
63
478.77
D
14234
D
Common Stock
2020-04-01
4
S
0
69
479.0
D
14165
D
Common Stock
2020-04-01
4
S
0
58
480.28
D
14107
D
Common Stock
2020-04-01
4
S
0
62
482.09
D
14045
D
Common Stock
2020-04-01
4
S
0
124
483.58
D
13921
D
Common Stock
2020-04-01
4
S
0
3
484.14
D
13918
D
Common Stock
2020-04-01
4
S
0
137
488.76
D
13781
D
Common Stock
2020-04-01
4
S
0
201
489.48
D
13580
D
Common Stock
2020-04-01
4
S
0
70
491.65
D
13510
D
Common Stock
2020-04-01
4
S
0
134
492.45
D
13376
D
Common Stock
2020-04-01
4
S
0
174
493.24
D
13202
D
Common Stock
2020-04-01
4
S
0
37
494.16
D
13165
D
Common Stock
2020-04-01
4
S
0
68
497.99
D
13097
D
Common Stock
1401
I
By 401(k) Plan
Common Stock
1897
I
By Trust
Common Stock
509
I
by 2017 GRAT
Common Stock
2284
I
by 2018 GRAT
Incentive Stock Option (right to buy)
30.63
2020-04-01
4
M
0
1200
0.0
D
2020-12-14
Common Stock
1200
2180
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 124 shares of Company stock on April 1, 2020 at prices ranging from $483.35 to $483.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price.
Represents volume-weighted average price of sales of 137 shares of Company stock on April 1, 2020 at prices ranging from $488.57 to $488.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price.
Represents volume-weighted average price of sales of 201 shares of Company stock on April 1, 2020 at prices ranging from $489.17 to $489.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price.
Represents volume-weighted average price of sales of 134 shares of Company stock on April 1, 2020 at prices ranging from $492.07 to $492.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price.
Represents volume-weighted average price of sales of 174 shares of Company stock on April 1, 2020 at prices ranging from $493.14 to $493.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price.
These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
/s/**Christopher R. Fenimore
2020-04-02